Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Bristol-Myers Squibb Co (BMY) – Bristol-Myers Squibb Co Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bristol-Myers Squibb (BMY) trades at $56.45, up 1.4% on the day, with a bearish technical signal but strong recent earnings performance. The company has beaten EPS estimates for three consecutive quarters, including Q1 2026 ($1.58 vs. $1.42 expected), driven by newer drugs like Breyanzi and Camzyos. Valuation appears reasonable with a P/E of 15.8 and a 4.3% dividend yield. Recent news highlights pipeline progress, including European approval for Sotyktu in psoriatic arthritis and a positive shareholder meeting.
The outlook balances a robust growth portfolio and cost-saving initiatives against a significant patent cliff for key drugs. Upside is supported by a consensus price target of $66.14 (17% upside) and a high-yield dividend. Primary risks include execution on pipeline commercialization, debt management (debt-to-asset ratio of 53.6% in 2024), and competitive pressures in oncology and immunology.
Read full analysis

Key Stats

  • Market Cap
    $115.15B
  • Sector
    Health
  • 3M Drawdown
    -10.74%
  • Enterprise Value
    $151.09B
  • Dividend Yield
    4.47%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    93 days
$56.17
52W Low: $42.6
29 Oct 2025
52W High: $62.37
27 Feb 2026

Bristol-Myers Squibb Co (BMY) is currently valued at a market capitalization of $115.15B, with an enterprise value of $151.09B. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $62.37, highlighting its annual price range. Over the past three months, Bristol-Myers Squibb Co has recorded a drawdown of -10.74%, reflecting recent price volatility. Bristol-Myers Squibb Co offers a dividend yield of 4.47%, with the most recent dividend of $0.63 paid on 02 Apr 26. On average, investors hold Bristol-Myers Squibb Co for approximately 93 days, indicating typical investor behavior on the platform.

About Bristol-Myers Squibb Co

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.


Technical Indicators
|
|
|
Overall Summary
Bearish (17)Neutral (3)Bullish (7)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $115.15B
  • Sector
    Health
  • 3M Drawdown
    -10.74%
  • Enterprise Value
    $151.09B
  • Dividend Yield
    4.47%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    93 days
$56.17
52W Low: $42.6
29 Oct 2025
52W High: $62.37
27 Feb 2026

Bristol-Myers Squibb Co (BMY) is currently valued at a market capitalization of $115.15B, with an enterprise value of $151.09B. Over the past 52 weeks, Bristol-Myers Squibb Co has traded between a low of $42.6 and a high of $62.37, highlighting its annual price range. Over the past three months, Bristol-Myers Squibb Co has recorded a drawdown of -10.74%, reflecting recent price volatility. Bristol-Myers Squibb Co offers a dividend yield of 4.47%, with the most recent dividend of $0.63 paid on 02 Apr 26. On average, investors hold Bristol-Myers Squibb Co for approximately 93 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!